Nivolumab, an immune checkpoint inhibitor lauded for its groundbreaking approach to cancer treatment, marked its 10th ...

Despite keen interest in BAFF-R inhibition, rheumatologists favor BMS’ Sotyktu (deucravacitinib) as the leading therapy in development for Sjögren’s.EXTON, PA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- ...

Indigenous addiction treatment centres in Alberta are delaying a program developed for the province because of a lack of ...

These drugs are “very effective, but they’re scary and they’re chaotic and they’re unpredictable,” says Dillan DiNardo, CEO ...

BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.

Volastra Therapeutics, a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to VLS-1488, the company’s internally ...

Opinion: When should marijuana use deny a patient an organ transplant? It’s a more complicated question than you think.

Across medtech, companies have continued to innovate through the first nine months of 2024, and that rings especially true in ...

Drug overdose deaths are dropping across the Kansas City metro area, matching recently announced national trends. It’s a ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...

It also prohibits sitting, lying down, sleeping or camping on “sensitive use” properties, including schools, child care facilities, parks, libraries, government buildings, warming or cooling centers ...